How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?

The Canadian journal of urology

Volumn 12, Issue 1, 2005, Pages 2547-2552

  Choo, Richard ^a   Chander, Sarat ^a   Danjoux, Cyril ^a   Morton, Gerard ^a   Pearce, Andrew ^a   Deboer, Gerrit ^a   Szumacher, Ewa ^a   Loblaw, Andrew ^a   Cheung, Patrick ^a   Woo, Tony ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BUSERELIN; HEMOGLOBIN; IMIDAZOLIDINE DERIVATIVE; NILUTAMIDE; TESTOSTERONE;

ADJUVANT THERAPY; AGED; ANEMIA; ARTICLE; BLOOD; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PROSTATE TUMOR; SICKNESS IMPACT PROFILE;

AGED; ANDROGEN ANTAGONISTS; ANEMIA; ANTINEOPLASTIC AGENTS, HORMONAL; BUSERELIN; CLINICAL TRIALS, PHASE II; HEMOGLOBINS; HUMANS; IMIDAZOLIDINES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SICKNESS IMPACT PROFILE; TESTOSTERONE;

EID: 20144363318     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)